UPDATE: J.P. Morgan Raises PT on Cabot to $50 (CBT)

J.P. Morgan is out with its report today on Cabot CBT, raising its PT from $44 to $50. In a note to clients, J.P. Morgan writes, "We raised our December 2011 price target for Cabot from $44.00 to $50.00, which is consistent with the current share price reflecting our earnings adjustments and generally higher equity valuations for cyclical stocks in the market. Our price target is based on a 6.9x EV/EBITDA multiple for 2011E, which is in the range of a comparable peer group average of 5.3-10.0x EV/EBITDA for 2011E." J.P. Morgan maintains Neutral on CBT. Shares of CBT closed Thursday at $46.07, down 2.83% from Wednesday's close.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorPrice TargetAnalyst RatingsCabotDiversified ChemicalsJ.P. MorganMaterials
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!